BCWorldPharm Co Ltd
KOSDAQ:200780
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Ben Thanh Rubber JSC
VN:BRC
|
VN |
BCWorldPharm Co Ltd
Inventory
BCWorldPharm Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BCWorldPharm Co Ltd
KOSDAQ:200780
|
Inventory
₩21.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
9%
|
|
|
Yuhan Corp
KRX:000100
|
Inventory
₩372.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Inventory
₩100.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Inventory
₩338.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Inventory
₩47.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Inventory
₩22.7B
|
CAGR 3-Years
41%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
BCWorldPharm Co Ltd
Glance View
BCWORLD PHARM.Co., Ltd. engages in the manufacture and development of pharmaceutical products. The company is headquartered in Yeoju, Gyeonggi-Do. The company went IPO on 2014-12-15. The firm's products include anesthetic pain medication such as cancer pain treatment, muscle relaxants, anesthesia and pain relief drugs; circulation contracts such as hypertension and hyperlipidemia; antibiotics such as tuberculosis treatment; other prescription drugs such as peptic ulcer and osteoporosis. In addition, the Company develops improved drugs and new products.
See Also
What is BCWorldPharm Co Ltd's Inventory?
Inventory
21.3B
KRW
Based on the financial report for Dec 31, 2025, BCWorldPharm Co Ltd's Inventory amounts to 21.3B KRW.
What is BCWorldPharm Co Ltd's Inventory growth rate?
Inventory CAGR 10Y
9%
Over the last year, the Inventory growth was 44%. The average annual Inventory growth rates for BCWorldPharm Co Ltd have been 8% over the past three years , -4% over the past five years , and 9% over the past ten years .
